FDA — authorised 27 August 2019
- Marketing authorisation holder: KYOWA KIRIN
- Status: approved
🇺🇸 Nourianz in United States
FDA authorised Nourianz on 27 August 2019
Marketing authorisations
FDA — authorised 27 August 2019
- Application: NDA022075
- Marketing authorisation holder: KYOWA KIRIN
- Local brand name: NOURIANZ
- Indication: TABLET — ORAL
- Status: approved
Nourianz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Nourianz approved in United States?
Yes. FDA authorised it on 27 August 2019; FDA authorised it on 27 August 2019.
Who is the marketing authorisation holder for Nourianz in United States?
KYOWA KIRIN holds the US marketing authorisation.